Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Ethambutol hydrochloride
Pfizer Healthcare Ireland
J04AK; J04AK02
Ethambutol hydrochloride
400 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Other drugs for treatment of tuberculosis; ethambutol
Not marketed
1977-04-01
PATIENT INFORMATION LEAFLET ETHAMBUTOL* 400MG TABLETS (ETHAMBUTOL HYDROCHLORIDE) WHAT YOU SHOULD KNOW ABOUT ETHAMBUTOL TABLETS This leaflet provides important information about your medicine. Please read it carefully before you start taking ETHAMBUTOL Tablets. If you have any questions, or there is anything you do not understand, ask your doctor or pharmacist (chemist). Keep this leaflet while you are taking ETHAMBUTOL Tablets, you may want to read it again. WHAT IS IN ETHAMBUTOL TABLETS? ETHAMBUTOL Tablets contain 400mg ethambutol hydrochloride in each film- coated tablet. ETHAMBUTOL belongs to a group called antituberculous drugs. Other ingredients in ETHAMBUTOL Tablets are: Sucrose, gelatin 125 bloom, sorbitol solution 70%, magnesium stearate, stearic acid, polydextrose, hypromellose, macrogol 4000, titanium dioxide (E171), iron oxide yellow (E172) and iron oxide black (E172). The licence holder is: Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. The manufacturer is: Wyeth Laboratories, New Lane, Havant, Hants PO9 2NG, England. ETHAMBUTOL Tablets are licensed in bottles of 56, 100 and 500 grey film- coated tablets. ETHAMBUTOL Tablets are supplied in bottles of 56 grey film-coated tablets. WHAT CAN ETHAMBUTOL TABLETS BE USED TO TREAT? ETHAMBUTOL Tablets are used for the treatment and prevention of tuberculosis, an infectious disease mainly affecting the lungs. BEFORE TAKING THIS MEDICINE If the answer to any of the following questions is "YES" you should talk to your doctor before taking any tablets as they may not be suitable for you: • do you have sight problems? Ref: EL 3_0 Page 1 of 4 2014-0006167 • are you pregnant, breast feeding or trying for a baby ? • have you ever had an allergic reaction to any of the ingredients in ETHAMBUTOL TABLETS (see “What is in ETHAMBUTOL TABLETS” above)? • do you have kidney or liver_ _ problems ? • are you taking any other medicines or tablets including any that you have bought without a prescription Citiți documentul complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ethambutol 400mg Film Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 400 mg Ethambutol Hydrochloride. Excipients: Each tablet contains 130mg sucrose and 23mg sorbitol. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. Smooth, grey, biconvex, bevel-edged film coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large- tuberculin-positive reaction. Ethambutol should only be used in conjunction with other anti-tuberculous drugs to which the patient’s organisms are susceptible. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Route of administration:_ Oral _Posology:_ Recommended Dosage The dosage of ethambutol must be carefully calculated on the basis of individual body weight to minimise the risk of toxicity. Adults: The usual daily dosage is 15-25 mg/kg body weight given as a single dose. Children: The usual daily dosage is 20 (15-25) mg/kg body weight given as a single dose. Higher doses may be required, this is to be handled on a case by case basis with specialists in the field. Dosing in infants less than 3 months is not recommended due to lack of data in this population. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _0_ _/_ _0_ _3_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _2_ _1_ _5_ _9_ _9_ _6_ _8_ _p_ _a_ _g_ _e_ _ _ _ Citiți documentul complet